By combing through genomic data of over 1 million people, scientists have identified genes commonly inherited across addiction disorders, regardless of the substance being used. This dataset—one of the largest of its kind—may ...
Mar 22, 2023
0
55
When COVID-19 hit the Mid-South in 2020, researchers at the University of Tennessee Health Science Center quickly saw how Memphis was struggling to keep pace with the rapid advance of the pandemic. So, they got to work.
Jan 23, 2023
0
12
Compared to men, we know much less about how women experience disease.
Dec 12, 2022
0
1064
Actors may suppress their core sense of self when acting, as they immerse themselves in a new role, finds a new study by UCL researchers.
Oct 26, 2022
0
29
Using a wearable activity tracker to count and increase the number and intensity of steps taken daily can reduce the risk of several common chronic diseases, including diabetes, hypertension, obesity, and sleep apnea, Vanderbilt ...
Oct 12, 2022
0
110
Research findings posted online as preprints—studies made public before undergoing the review and approval of a panel of peer scientists required by most scholarly journals—often hold up quite well to that scrutiny, according ...
Oct 12, 2022
0
70
Researchers have developed a low-cost, simple imaging system that uses tumor-targeting fluorescent molecules to determine the depth of tumor cells in the body. The portable system could eventually help surgeons distinguish ...
Oct 6, 2022
0
9
Immune checkpoint inhibitor (ICI) therapy is a type of treatment for melanoma, the deadliest form of skin cancer, which blocks proteins on tumor or immune cells that prevent the immune system from killing cancer cells.
Sep 19, 2022
0
1486
Cedars-Sinai investigators have created the most bio-realistic and complex computer models of individual brain cells—in unparalleled quantity. Their research, published today in the peer-reviewed journal Cell Reports, details ...
Aug 9, 2022
0
93
SARS-CoV-2 variants of concern and the biological sex of patients affect the efficacy of molnupiravir, the first orally available drug approved for outpatient use against COVID-19, according to a new study led by researchers ...
Aug 1, 2022
0
37
